BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/24/0.1/20.09.24 Share Price

Warrant

G92NB

NLBNPFR1Z9P1

Market Closed - Euronext Paris 17:30:02 17/05/2024 BST
0.025 EUR 0.00% Intraday chart for BNP PARIBAS ARBITRAGE/PUT/PFIZER INC/24/0.1/20.09.24
Current month-78.26%
1 month-81.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/05/24 0.025 0.00%
16/05/24 0.025 0.00%
15/05/24 0.025 -28.57%
14/05/24 0.035 0.00%
13/05/24 0.035 0.00%

Real-time Euronext Paris

Last update May 17, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
G92NB
ISINNLBNPFR1Z9P1
Date issued 05/03/2024
Strike 24 $
Maturity 20/09/2024 (126 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.14
Lowest since issue 0.025
Delta-0.11x
Omega 11.90
Premium17.11x
Gearing105.35x
Moneyness 0.8384
Difference Strike -4.64 $
Difference Strike %-19.33%
Spread 0.01
Spread %33.33%
Theoretical value 0.0250
Implied Volatility 27.37 %
Total Loss Probability 85.12 %
Intrinsic value 0.000000
Present value 0.0250
Break even 23.73 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.64 USD
Average target price
31.94 USD
Spread / Average Target
+11.52%
Consensus
  1. Stock Market
  2. Warrants
  3. G92NB Warrant